Cetera Investment Advisers Buys 5,302 Shares of DocuSign, Inc. (NASDAQ:DOCU)

Cetera Investment Advisers boosted its stake in DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 11.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 50,329 shares of the company's stock after purchasing an additional 5,302 shares during the quarter. Cetera Investment Advisers' holdings in DocuSign were worth $4,527,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also added to or reduced their stakes in DOCU. Captrust Financial Advisors raised its holdings in shares of DocuSign by 8.8% in the 4th quarter. Captrust Financial Advisors now owns 41,989 shares of the company's stock valued at $3,776,000 after acquiring an additional 3,402 shares in the last quarter. Cary Street Partners Financial LLC purchased a new position in shares of DocuSign during the 4th quarter valued at about $5,505,000. Baker Avenue Asset Management LP raised its holdings in shares of DocuSign by 782.8% during the 4th quarter. Baker Avenue Asset Management LP now owns 28,575 shares of the company's stock valued at $2,570,000 after buying an additional 25,338 shares in the last quarter. Ameriprise Financial Inc. raised its holdings in shares of DocuSign by 24.7% during the 4th quarter. Ameriprise Financial Inc. now owns 1,186,106 shares of the company's stock valued at $106,703,000 after buying an additional 235,145 shares in the last quarter. Finally, Alyeska Investment Group L.P. purchased a new position in shares of DocuSign during the 4th quarter valued at about $37,020,000. Institutional investors own 77.64% of the company's stock.

DocuSign Stock Performance

Shares of DOCU stock opened at $90.27 on Thursday. The firm has a market cap of $18.28 billion, a P/E ratio of 18.61, a P/E/G ratio of 6.94 and a beta of 1.21. DocuSign, Inc. has a fifty-two week low of $48.70 and a fifty-two week high of $107.86. The business's 50 day moving average price is $80.68 and its 200-day moving average price is $84.79.

DocuSign (NASDAQ:DOCU - Get Free Report) last issued its quarterly earnings data on Thursday, March 13th. The company reported $0.86 earnings per share for the quarter, topping analysts' consensus estimates of $0.84 by $0.02. The firm had revenue of $776.25 million for the quarter, compared to analyst estimates of $760.94 million. DocuSign had a return on equity of 14.90% and a net margin of 34.73%. The business's quarterly revenue was up 9.0% compared to the same quarter last year. During the same period last year, the company earned $0.76 EPS. As a group, equities analysts predict that DocuSign, Inc. will post 1.17 EPS for the current year.

Insider Transactions at DocuSign

In related news, Director Teresa Briggs sold 534 shares of DocuSign stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $87.41, for a total transaction of $46,676.94. Following the sale, the director now directly owns 8,270 shares in the company, valued at $722,880.70. The trade was a 6.07% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Blake Jeffrey Grayson sold 16,111 shares of DocuSign stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $83.20, for a total value of $1,340,435.20. Following the sale, the chief financial officer now owns 93,960 shares in the company, valued at $7,817,472. This represents a 14.64% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 55,851 shares of company stock worth $4,607,439. 1.66% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on DOCU shares. Wells Fargo & Company decreased their price objective on DocuSign from $73.00 to $65.00 and set an "underweight" rating on the stock in a report on Tuesday, April 22nd. Hsbc Global Res raised DocuSign from a "moderate sell" rating to a "hold" rating in a report on Friday, April 11th. Royal Bank of Canada restated a "sector perform" rating and set a $90.00 price target on shares of DocuSign in a research report on Friday, March 14th. William Blair restated an "outperform" rating on shares of DocuSign in a research report on Monday, April 21st. Finally, Wedbush restated a "neutral" rating and set a $100.00 price target on shares of DocuSign in a research report on Friday, March 14th. One investment analyst has rated the stock with a sell rating, eleven have issued a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and an average price target of $92.46.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.